# Two Tuberculosis Regimens Containing Novel Agents Show Promise

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/infectiousdisease/tuberculosis/123970) · 2026-11-19 · Medicine
Page: https://themorning.science/story/two-tuberculosis-regimens-containing-novel-agents-show-promise-4dada845570b7d30
Kind: research · Impact: medium

## In brief

- Two new 16-week tuberculosis regimens advanced in a clinical trial, according to reports dated 2026-11-19.
- Both regimens are four-drug combinations that pair novel agents with commonly used drugs.
- Results from a phase II trial suggested the regimens show promise and should be evaluated further.

## Why it matters

Tuberculosis treatment is long and burdened by side effects, so shorter 16-week regimens with new agents could matter for patients and for TB drug development if later trials confirm the early results.

## Timeline

- 2026-11-19: Results of phase II trial of two four-drug tuberculosis regimens reported

## Coverage

- [Two Tuberculosis Regimens Containing Novel Agents Show Promise](https://www.medpagetoday.com/infectiousdisease/tuberculosis/123970) — MedPageToday.com - medical news for physicians, 2026-11-19
- [Two new 16-week tuberculosis regimens advance in clinical trial](https://medicalxpress.com/news/2026-11-week-tuberculosis-regimens-advance-clinical.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: tuberculosis, clinical trial, antibiotics, drug regimen, infectious disease

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
